Advertisement

Lapatinib and letrozole as first-line therapy for metastatic breast cancer: case report of bone metastasis 18 years later

Abstract

We describe a 63-year-old woman with a diagnosis of breast cancer who relapsed with multiple bone lesions 18 years later. The biological characteristics were estrogen receptor positive, progesterone receptor positive, and HER2-positive cancer. Lapatinib and letrozole was the treatment of choice as a manageable and active first-line therapy for this patient.

Tumori 2013; 99(6): e264 - e268

Article Type: CASE REPORT

DOI:10.1700/1390.15465

Authors

Gabriella Mariani, Francesca Ricchini, Lorenzo Sica, Giulia Valeria Bianchi

Article History

This article is available as full text PDF.

  • If you are a Subscriber, please log in now.

  • Article price: Eur 36,00
  • You will be granted access to the article for 72 hours and you will be able to download any format (PDF or ePUB). The article will be available in your login area under "My PayPerView". You will need to register a new account (unless you already own an account with this journal), and you will be guided through our online shop. Online purchases are paid by Credit Card through PayPal.
  • If you are not a Subscriber you may:
  • Subscribe to this journal
  • Unlimited access to all our archives, 24 hour a day, every day of the week.

Authors

  • Mariani, Gabriella [PubMed] [Google Scholar]
    Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
  • Ricchini, Francesca [PubMed] [Google Scholar]
    Oncologia Medica 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
  • Sica, Lorenzo [PubMed] [Google Scholar]
    Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
  • Bianchi, Giulia Valeria [PubMed] [Google Scholar]
    Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy

Article usage statistics

The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.

No supplementary material is available for this article.